Studies on the hearts of mice confirmed that SIRT6 inhibits the activation of the IGF-Akt signal by inhibiting c-Jun transcriptional activity and deacetylation in H3K9, thereby blocking cardiac hypertrophy. The gene discussed is IGF1; the disease is cardiac hypertrophy.